title: DNA methylation modifications associated with chronic fatigue syndrome.
abstract: Chronic Fatigue Syndrome (CFS), also known as myalgic encephalomyelitis, is a complex multifactorial disease that is characterized by the persistent presence of fatigue and other particular symptoms for a minimum of 6 months. Symptoms fail to dissipate after sufficient rest and have major effects on the daily functioning of CFS sufferers. CFS is a multi-system disease with a heterogeneous patient population showing a wide variety of functional disabilities and its biological basis remains poorly understood. Stable alterations in gene function in the immune system have been reported in several studies of CFS. Epigenetic modifications have been implicated in long-term effects on gene function, however, to our knowledge, genome-wide epigenetic modifications associated with CFS have not been explored. We examined the DNA methylome in peripheral blood mononuclear cells isolated from CFS patients and healthy controls using the Illumina HumanMethylation450 BeadChip array, controlling for invariant probes and probes overlapping polymorphic sequences. Gene ontology (GO) and network analysis of differentially methylated genes was performed to determine potential biological pathways showing changes in DNA methylation in CFS. We found an increased abundance of differentially methylated genes related to the immune response, cellular metabolism, and kinase activity. Genes associated with immune cell regulation, the largest coordinated enrichment of differentially methylated pathways, showed hypomethylation within promoters and other gene regulatory elements in CFS. These data are consistent with evidence of multisystem dysregulation in CFS and implicate the involvement of DNA modifications in CFS pathology.
authors.affiliation: Centre for Environmental Epigenetics and Development, University of Toronto, Scarborough, ON, Canada; Department of Biological Sciences, University of Toronto, Scarborough, ON, Canada; Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
authors.forename: Wilfred C
authors.initials: WC
authors.lastname: de Vega
authors.affiliation: CFIDS Association of America, Charlotte, North Carolina, United States of America.
authors.forename: Suzanne D
authors.initials: SD
authors.lastname: Vernon
authors.affiliation: Centre for Environmental Epigenetics and Development, University of Toronto, Scarborough, ON, Canada; Department of Biological Sciences, University of Toronto, Scarborough, ON, Canada; Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada.
authors.forename: Patrick O
authors.initials: PO
authors.lastname: McGowan
mesh_terms: D000328:Adult; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation; D015673:Fatigue Syndrome, Chronic / Q000235:genetics*; D005260:Female; D063990:Gene Ontology; D053263:Gene Regulatory Networks; D006801:Humans; D008297:Male
references.citation: J Intern Med. 2012 Jan;271(1):64-81
references.pmid: 21615807
references.citation: Bioinformatics. 2010 Nov 15;26(22):2927-8
references.pmid: 20926419
references.citation: Genome Biol. 2012 Oct 03;13(10):R97
references.pmid: 23034122
references.citation: J Clin Pathol. 2005 Aug;58(8):826-32
references.pmid: 16049284
references.citation: Oncotarget. 2013 Nov;4(11):2067-79
references.pmid: 24162015
references.citation: Proc Natl Acad Sci U S A. 2013 May 14;110(20):8302-7
references.pmid: 23630272
references.citation: Neuropsychol Rev. 2005 Mar;15(1):29-58
references.pmid: 15929497
references.citation: Scand J Immunol. 1994 Dec;40(6):601-8
references.pmid: 7997849
references.citation: Nat Rev Immunol. 2004 May;4(5):348-59
references.pmid: 15122200
references.citation: Clin Exp Immunol. 2005 Aug;141(2):326-32
references.pmid: 15996197
references.citation: Ann Med. 2001 Jul;33(5):350-7
references.pmid: 11491194
references.citation: J Immunol. 1987 Nov 15;139(10):3306-13
references.pmid: 2824604
references.citation: World J Biol Psychiatry. 2008;9(3):165-71
references.pmid: 17853290
references.citation: J Clin Pathol. 2007 Feb;60(2):117-9
references.pmid: 16935963
references.citation: Epigenetics. 2013 Aug;8(8):802-6
references.pmid: 23811543
references.citation: BMC Med Genomics. 2013 Dec 27;6:58
references.pmid: 24373378
references.citation: Brain Behav Immun. 2012 Nov;26(8):1202-10
references.pmid: 22732129
references.citation: Clin Exp Immunol. 2003 May;132(2):360-5
references.pmid: 12699429
references.citation: Nat Protoc. 2009;4(1):44-57
references.pmid: 19131956
references.citation: Cytokine. 1991 Jul;3(4):292-8
references.pmid: 1873478
references.citation: Semin Hematol. 2013 Jan;50(1):38-47
references.pmid: 23507482
references.citation: J Infect Dis. 2008 Apr 15;197(8):1171-84
references.pmid: 18462164
references.citation: J Intern Med. 1997 Dec;242(6):465-78
references.pmid: 9437407
references.citation: Brain Behav Immun. 2007 Nov;21(8):1063-74
references.pmid: 17544255
references.citation: PLoS One. 2012;7(7):e41361
references.pmid: 22848472
references.citation: Autoimmun Rev. 2009 Feb;8(4):287-91
references.pmid: 18801465
references.citation: Curr Rheumatol Rep. 2007 Dec;9(6):482-7
references.pmid: 18177602
references.citation: Pharmacogenomics. 2006 Apr;7(3):395-405
references.pmid: 16610950
references.citation: PLoS One. 2010 Nov 15;5(11):e13984
references.pmid: 21085593
references.citation: Nat Rev Rheumatol. 2011 May;7(5):263-71
references.pmid: 21343899
references.citation: Clin Exp Immunol. 2005 Dec;142(3):505-11
references.pmid: 16297163
references.citation: Nature. 2004 Jan 8;427(6970):167-71
references.pmid: 14695475
references.citation: Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):87-95
references.pmid: 15110792
references.citation: Ann Intern Med. 1994 Dec 15;121(12):953-9
references.pmid: 7978722
references.citation: Trends Genet. 2012 Oct;28(10):506-14
references.pmid: 22824525
references.citation: Curr Opin Psychiatry. 2009 Jan;22(1):75-83
references.pmid: 19127706
references.citation: Clin Exp Immunol. 2004 Feb;135(2):294-302
references.pmid: 14738459
references.citation: Pharmacogenomics. 2006 Apr;7(3):345-54
references.pmid: 16610945
references.citation: J Neuroimmunol. 2001 Oct 1;119(2):343-9
references.pmid: 11585638
references.citation: Int J Endocrinol. 2013;2013:678159
references.pmid: 23690772
references.citation: Clin Immunol Immunopathol. 1993 Dec;69(3):253-65
references.pmid: 8242898
references.citation: Genome Biol. 2013 May 22;14(5):R42
references.pmid: 23697701
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9
references.pmid: 16009939
references.citation: Neuropsychobiology. 2011;64(4):183-94
references.pmid: 21912186
references.citation: Neurotherapeutics. 2013 Oct;10(4):782-8
references.pmid: 23963788
references.citation: J Biol Chem. 2002 Dec 20;277(51):49205-11
references.pmid: 12368275
references.citation: Genomics. 2011 Oct;98(4):288-95
references.pmid: 21839163
references.citation: J Autoimmun. 2013 Mar;41:6-16
references.pmid: 23306098
references.citation: Brief Funct Genomics. 2013 Nov;12(6):483-8
references.pmid: 23814131
references.citation: Behav Brain Funct. 2008 Sep 26;4:44
references.pmid: 18822143
references.citation: Lancet. 1999 Sep 11;354(9182):936-9
references.pmid: 10489969
references.citation: Nature. 2010 Jun 10;465(7299):721-7
references.pmid: 20535201
references.citation: Nature. 2012 Feb 15;483(7390):479-83
references.pmid: 22343889
references.citation: J Clin Microbiol. 1990 Jun;28(6):1403-10
references.pmid: 2166084
references.citation: BMC Syst Biol. 2008 Nov 06;2:95
references.pmid: 18986552
references.citation: Child Dev. 2013 Jan-Feb;84(1):58-75
references.pmid: 21883162
references.citation: Epigenomics. 2011 Dec;3(6):771-84
references.pmid: 22126295
references.citation: Physiol Behav. 2007 Dec 5;92(5):963-8
references.pmid: 17655887
references.citation: J Health Psychol. 2016 Jan;21(1):3-15
references.pmid: 24510231
references.citation: Immunology. 2013 Jul;139(3):285-93
references.pmid: 23521628
references.citation: Bioinformatics. 2012 Mar 1;28(5):729-30
references.pmid: 22253290
references.citation: Epigenetics. 2011 Jun;6(6):692-702
references.pmid: 21593595
references.citation: Dis Markers. 2002;18(4):193-9
references.pmid: 12590173
references.citation: Clin Exp Allergy. 2003 Oct;33(10):1450-6
references.pmid: 14519154
references.citation: Epigenetics. 2013 Jul;8(7):694-702
references.pmid: 23803720
references.citation: Brain Behav Immun. 2010 Oct;24(7):1209-17
references.pmid: 20447453
references.citation: Pharmacogenomics. 2006 Apr;7(3):375-86
references.pmid: 16610948
references.citation: Nat Biotechnol. 2013 Feb;31(2):142-7
references.pmid: 23334450
references.citation: Epigenetics. 2013 Feb;8(2):203-9
references.pmid: 23314698
references.citation: Br J Haematol. 1995 Jul;90(3):526-31
references.pmid: 7646989
references.citation: Cost Eff Resour Alloc. 2004 Jun 21;2(1):4
references.pmid: 15210053
references.citation: BMJ. 2006 Sep 16;333(7568):575
references.pmid: 16950834
references.citation: QJM. 2013 Jan;106(1):3-9
references.pmid: 22927538
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17253-60
references.pmid: 23045638
references.citation: Maturitas. 2010 Dec;67(4):316-20
references.pmid: 20813470
references.citation: Carcinogenesis. 2013 Jan;34(1):102-8
references.pmid: 23054610
references.citation: Microbiol Rev. 1991 Sep;55(3):451-8
references.pmid: 1943996
references.citation: Nurs Res Pract. 2013;2013:795784
references.pmid: 24058735
references.citation: Endocr Rev. 2003 Apr;24(2):236-52
references.pmid: 12700181